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Abstract Using a specific myofibroblast contraction test,
we try to predict future utero-vaginal prolapse development
in young primiparae women. We compare myofibroblast
cultures of the vaginal wall in primiparae women (group 1),
young multiparae women (group 2) and older multiparae
women (group 3) who were operated on for severe utero-
vaginal prolapse. A myofibroblast-mediated collagen gel
contraction assay determined a contraction factor that was
compared in the three groups of women. The myofibro-
blasts contraction factor after 24 and 48 hours was
significantly higher in group 1 women (2.4±0.6/4.4±1.9)
compared to group 2 (1.6±0.3/ 1.8±0.1) andgroup 3 (1.6±
0.3/1.8±0.3), but showed no differences in group 1 women
without (2.1±0.5/3.5±1.9) and with (2.7±0.6/5.1±1.7)
cystocoele. Vaginal myofibroblasts of young women show
better contraction forces than young women with severe
utero-vaginal prolapse. The latter have a myofibroblast
contraction factor similar to those of older post-menopausal
women operated for the same condition.
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Introduction
Although there have been very few prevalence studies using
the International Continence Society-validated pelvic organ
prolapse test for the objective assessment of utero-vaginal
prolapse disorders, these disorders are very common. A study
by Swift et al. [1] demonstrated that the prevalence of stage 1
prolapse was greater than 93% in a population of 497 women
seen in an outpatient clinic, with a mean age of 44 years seen in
an outpatient clinic, the prevalence of stage 2 being 48% and
that of stage 3, 3%. A Swedish study based on a non-validated
genital examination of a population of 487 women (mean age
39 years) found a prevalence of 31% for prolapse of any stage
and a prevalence of 1.6% for prolapse to introitus [2].
Fibroblasts are found in urothelial tissues [3] and have
the potential to transform into myofibroblasts, which are
rich in actin/myosin filaments. We were interested in
whether such cells may be important factors in healing the
anchoring tissues in the genital area after the “birth trauma”
of vaginal delivery.
We previously carried out a study of the contractile force
of these cells in prolapse and non-prolapse situations [4].
The first aim of the present study was to determine and
compare the contractile force of pelvic floor myofibroblasts
in a population of young primiparae women to that of a
population of young women who had given birth several
years previously before undergoing an operation for severe
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utero-vaginal prolapse and in a population of older women
operated on for the same condition. The second aim of the
study was to correlate the contractile force of myofibro-
blasts in the young primiparae women with the presence or
absence of some degree of utero-vaginal prolapse evaluated
6 months after delivery, trying to find a specific test to
predict future utero-vaginal prolapse development when
comparing the results obtained in women without and in
women with some degrees of prolapse.
Materials and methods
The subjects consisted of three groups of women:
Group 1: 15 primiparous women, 29 ± 4-years-old, who
underwent spontaneous non-instrumented delivery.
Group 2: four women, 37 ± 2-years-old (P:< 0.001)
para 2, operated on for severe (i.e., grade 3) utero-
vaginal prolapse, four to six years after their delivery.
Group 3: nine women, 64 ± 6-years-old, (P:< = 0.0001)
para 2 ± 1, operated on for severe (i.e., grade 3) utero-
vaginal prolapse.
Clinical examination
Clinical examination of subjects in groups 2 and 3 was
carried out with the women in a 45 degree position, such as
in birthing chair, according to the modified POP-Q ICS
classification [5]: all showed utero-vaginal grade 3 pro-
lapse. Clinical examination of group 1 was carried out 6–
12 weeks after vaginal delivery and a clinical grading of
vaginal wall prolapse was made using the same classifica-
tion; seven women had no anterior vaginal wall prolapse,
eight women had grade anterior vaginal wall prolapse grade
1 and 2 (six women: grade 1, two women grade 2).
Human tissues
Vaginal samples were obtained from surgical biopsy
samples of the posterior vaginal wall during episiotomy
repair in group 1 or during uterovaginal prolapse elective
surgical repair in groups 2 and 3, according to a protocol
approved by the Ethics Committee of the University
Hospital of Lausanne (protocol number 4902) and after
pre-delivery consent by group 1 patients and pre-operative
consent by patients in groups 2 and 3. During the 3 months
before surgery, all women in group 3 received intravaginal
estriol (Ortho-Gynest-D r, 3 mg) 1 to 2 times a week. The
fresh tissues were used to prepare cultures of myofibro-
blasts. The following are the methods for cell culture and
the collagen gel contraction assay [6]: Fifty thousand cells
were added to 500 mL of a 1:1 neutralized solution of rat
tail collagen (BD Biosciences, San Jose) in culture medium
that contained 4.5 g/L glucose, 10% fetal calf serum, and
6% methylcellulose (Sigma Chemical Company). At the
end of incubation, culture plates were scanned, and the
contraction factor of the myofibroblast-collagen gel was
quantified by measurement of the mean diameter of the
contracted plug after 24 hours or 48 hours of incubation.
The contraction factor was calculated as the ratio of the
diameter of the contracted plug to the initial diameter of the
well, i.e., 16 mm (Fig. 1).
Statistical methodology
Means and standard deviation for duplicate wells were
calculated. Statistical significance was assessed with one-
way analysis of variance and LSD test for post hoc
comparisons. A P value of <0.05 two-tailed was considered
as significant.
Prior to calculations, force test data after 24 and 48 hours
were tested for normality using the Kruskal–Wallis test.
Group 1 
23 years 
Group 2 
25 years 
Group 3
69 years
Group 3
73 years
• 50’000 cells are seeded in 500 µl of collagen and treated with antagonists 
to ETR or endothelin-1. 
• Every treatment is done in duplicate on cell cultures of women 
with prolapse (RX 34, SD 26) or without (GE 80, GS 78). 
•  Contraction of collagen gel is measured after 24 and 48 hours. 
Fig. 1 The myofibroblast
contraction force test in four
women: on the left side, two
young women of group 1
(without prolapse) and on the
right side, two older women of
group 3: the contraction factor
of the myofibroblast-collagen
gel is quantified by measure-
ment of the mean diameter of
the contracted plug after 24
hours or 48 hours of incubation
(black circles). The contraction
factor is determined as the ratio
of the diameter of the contracted
plug to the initial diameter of the
well
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Results
After 24 hours, the contractile force test gave a significant
higher value for myofibroblasts from group 1 (2.4±0.6)
than for those from group 2 (1.6±0.3, P = 0.004) or group 3
(1.6±0.3, P = 0.000).
After 48 hours, the contractile force was greater, but the
differences were still significant between groups 1 and
group 2 (4.4±1.9 and 1.8±0.3, respectively; P = 0.002) and
groups 1 and 3 (4.4±1.9 and 1.8±0.3, respectively; P =
0.000) (Fig. 2) (Table 1).
Post-partum examination of group 1 showed absence of
prolapse in seven women and the presence of grade 1 and 2
anterior vaginal prolapse in eight women. Comparison of the
myofibroblast contractile force between the seven women
without prolapse and the eight with grade 1 and 2 anterior
vaginal wall prolapse showed no significant difference.
Women with grade 1 or 2 anterior vaginal wall prolapse
showed similar contractile force values at 24 hours (2.1±0.5
and 2.7±0.6, respectively; P = 0.91) and at 48 hours (3.5±
1.9 and 5.1±1.7, respectively; P = 0.93) (Fig. 3a,b).
Discussion
Numerous studies have demonstrated an association of
prolapse disorders with pregnancy and vaginal delivery.
One study found that pregnancy itself is responsible for
some degree of prolapse, with a prevalence of 48% for
stage 2 prolapse determined by pelvic organ prolapse
quantification in pregnant primiparae women compared to
0% in a group of non-pregnant primiparae women [7].
Furthermore, vaginal delivery is considered the greatest
risk factor for the development of prolapse in women under
the age of 59, the relative risk being 8.4 for women with
two children and 10.9 for women with four children or
more compared to nulliparous women, after adjusting for
age [8]. Apart from spontaneous single delivery itself, other
vaginal delivery parameters (instrumental delivery, episiot-
omy, birth weight, management, and duration of the second
phase of labor) have been suggested as a possible etiology
of future prolapse disorders.
Consequently, “normal” vaginal delivery is responsible
for trauma to the tissues of the birth canal responsible for
utero-vaginal prolapse in about 50% of parous women, with
10% to 20% being symptomatic [9], and is the greatest risk
factor for the development of pelvic organ prolapse, with an
adjusted relative risk of 10.85 (95% CI, 4.65–33.81) [8, 10].
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Fig. 2 Myo-fibroblast contraction force test values in the three groups
of women: young delivered primiparae women of group 1 have
significant higher values when compared to young women with severe
utero-vaginal prolapse of group 2 and to older women of group 3 with
similar pathology
Table 1 Myo-fibroblasts contraction force test values in women of
group 1, women of group 2 and women of group 3 operated on for
severe utero-vaginal prolapse
Contraction
factor
Group 1
(N = 15)
(29±4 years)
Group 2
(N =4)
(37±2 years)
Group 3
(N =13,
64±6 years)
P Gr.1 vs.
Gr 2/3
After
24 hours
2.4±0.6 1.6±0.3 1.6±0.3 0.004/0.000
After
48 hours
4.4±1.9 1.8±0.3 1.8±0.3 0.002/0.000
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Fig. 3 a,b Contraction factor after 24 hours in group 1 women,
considering the absence (no cystocoele) and presence of grade I and II
anterior vaginal wall prolapse
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Race and hereditary factors are also implicated in the
genesis of such disorders due to heritable intrinsic connec-
tive tissue abnormalities: there is a higher risk of prolapse
in women with a mother (OR 3.2) or a sister (OR 2.4) who
have had a prolapse [11].
The etiology of the problem is poorly understood. One
hypothesis is that these utero-vaginal defects are related to
abnormal repair of the wounded tissue after the birth injury
of delivery [12]. Connective tissue abnormalities have been
described in many studies, which have shown a lower
collagen content [13], collagen abnormalities [14], and
higher expression of genes responsible for collagen
breakdown and lower expression of genes responsible for
collagen synthesis [15, 16]. These last studies showed that
the differences between patients with advanced pelvic
organ prolapse and controls may be related to the
differential expression in the pubococcygeus muscle of
genes for structural proteins related to actin and myosin and
for extracellular matrix proteins [16, 17].
These studies were all retrospective and were performed
on material obtained during pelvic floor surgery.
On the other hand, we know that fibroblasts transform
into myofibroblasts, which contain a highly developed
contractile apparatus similar to that in smooth muscle cells,
contain alpha-smooth muscle actin (α-SMA), and are
essential for establishing tension during repair phase and
are important in the synthesis of the extracellular matrix
[18, 19]. Myofibroblasts can temporarily acquire contractile
properties and the capacity to synthesize large amounts of
extracellular matrix components, among which collagen
type I predominates [20]. The participation of neo-
expressed contractile proteins, such as α-SMA, in force
generation by myofibroblast cells is now well accepted [21].
However, no study had assessed the functions of these
supporting and contractile cells (i.e., fibroblasts/myofibro-
blasts) in the pelvic floor of newly delivered women and
compared the fibroblast contractile force of this group to
that of young women who had undergone an operation for
grade 3 utero-vaginal prolapse several years after delivery
or that of older women operated on for the same pathology.
For obtaining tissues specimen, the posterior vaginal
wall was chosen for practical and evident reasons: it was
more easy and acceptable for the young women of group 1
to accept the idea of tissues biopsies in a place where there
is already or a wound (the episiotomy) or a tear who will be
surgically repaired. Subsequently, we took biopsies speci-
men in the same region when operating women of group 2
and 3 with severe prolapse.
The following could be another question: Is the vaginal
wall really the right structure to study in order to find a
factor of predictability of pelvic organ prolapse? All
biopsies specimens were deep excised taking each time
the sub-mucous layer, the latter being rich in fibroblasts and
being involved in the scarring process of birth trauma. For
obvious ethical reasons, we have not proposed biopsies in
other sites, such as the pelvic floor.
Other questions remain unresolved: Is the posterior
vaginal wall of young pregnant women representative of
normal myofibroblasts function? Is it possible to use these
specimens of vaginal wall as controls? Can their higher
contractile force be only a pregnancy effect? Can we
exclude that non-pregnant young women may have the
same results as prolapsed patients of groups 2 and 3? To
rule out this possibility, another study should be carried out
on biopsies taken from the posterior vaginal wall of young
non-pregnant women, but it is doubtful that such a study
would be accepted by an ethics committee.
Similarly, we cannot conclude that the lesser contractility
is the only cause of the prolapse in group 2 and group 3
women; this lowered contractility may perhaps simply be
what happens to myofibroblasts in the vaginal epithelium
when it has prolapsed or stretched over time. Up to now,
nobody has answeredthis question, and a control group of
women of same age as the women in group 3 should be
carried out with biopsies of posterior vaginal walls. This
too, however, would like be rejected by an ethics committee.
In a previous publication [4], we demonstrated that
myofibroblasts express the complete endothelin system, but
do not secrete endothelin-1, and that in 3-D collagen gels, the
spontaneous contraction of myofibroblasts from estrogen-
treated women with prolapse is significantly lower than that
of myofibroblasts from young primiparous women. We
concluded that the genital myofibroblasts of women with
uterovaginal prolapse are poorly contractile, and that endo-
thelin-1 further decreases vaginal myofibroblast contraction,
which contrasts with observations on skin myofibroblasts
[21].
In the present study, we compared the contractile force of
myofibroblasts in newly delivered women (group 1) and in
other young women who had undergone an operation for
severe utero-vaginal prolapse 4 to 6 years after spontaneous
delivery of normal weight babies (group 2). At 24 hours,
the contractile force of the myofibroblasts from group 2 was
significantly lower than that of the group 1 women of the
same age (1.6±0.3 and 2.4±0.6, respectively; p = 0.004)
Furthermore, the contractile force for group 2 was the same
as that for group 3 (1.6±0.3; p = 0.91 NS) consisting of
older women operated on for the same pathology, suggest-
ing a congenital weakness of these tissues.
We also showed that the myofibroblast contractile force
for group 1 increased with time in the test, ranging from
2.4±0.6 at 24 hours of incubation and 4.4±1.9 at 48 hours
(p=0.002), whereas the contractile force for the young
women in group 2 and the older women in group 3 was
significantly lower at 24 h (1.6±0.3 and 1.6±0.3, respec-
tively, p=0.004 and p=0.000) and did not increase with
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time (1.8±0.3 and 1.8±0.3, respectively; p = 0.30 NS and
p=0.08 NS) These results lead us to hypothesize that
myofibroblasts of young women with severe prolapse are
less able to affect tissue repair, explaining the development
of prolapse after delivery.
But it is not also possible to conclude that the lesser
contractility of group 2 and 3 is a cause of the prolapse; it
may simply be what happens to myofibroblasts in the vaginal
epithelium when it has prolapsed or stretched over time.
However, we were unable to demonstrate significant
differences between the myofibroblasts of group 1 women
with or without some degree of anterior vaginal wall
mobility during post-partum examination. This may be
explained by the small number of women and the low grade
of anterior vaginal wall prolapse (i.e., grade 1) in six of the
eight women studied. This finding should be investigated in
a study involving more patients. Another possibility could
be a close follow-up of these group 1 young women with
another clinical and biopsy one to two years after delivery
(we did controls six months after delivery); this aspect of
the study was discussed with these women, but none of
them accepted the idea of a second biopsy outside the
pregnancy-delivery-lactation period. This fact is responsible
for some limitations of our significant findings when
comparing the tissues of young delivered women with
those of young and older patients with established prolapse.
Why do some women have high myofibroblast contrac-
tile forces, while others have low ones? The myofibroblast
contractile force test is a global test, taking into account
many different factors; other cellular pathways are possible
pathways for explaining such differences. They have not
been investigated up to now.
In the field of screening tests for future prolapse
development, the study of the different factors responsible
for the contractile force of myofibroblasts may lead to the
definition of biomarkers allowing the development of a
specific test capable of replacing the expensive and
sophisticated myofibroblast contractile force test.
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